With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.

Novo Nordisk has been busy scaling its manufacturing ... limelight earlier this month with its controversial Super Bowl advert – offers compounded semaglutide. Shares in the company tumbled ...

By comparison, trials pivotal to getting Novo Nordisk's semaglutide — the ingredient ... offering samples for as little as 80p per dose. Adverts list it as a 'weight loss supplement', with ...

We also treat our community members to special offers, promotions, and adverts from us and our partners ... The Independent A spokesperson for Novo Nordisk, the maker of Ozempic, Rybelsus ...

Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...

In a statement, Trotter described his experience as a child with older relatives who struggled with Type 2 diabetes. Trotter ...